• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: toripalimab in combination with axitinib
Date Designated: 03/25/2020
Orphan Designation: Treatment of mucosal melanoma
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
TopAlliance Biosciences, Inc.
9430 Key West Ave, Suite 125
Rockville, Maryland 20850
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-